GLI2, another SHH signalling product, is stabilised by mTORC2 through the inactivation of GSK3β and subsequent inhibition of GLI2 ubiquitination, affecting GBM angiogenesis, metastasis, cell proliferation, and CSC’s regeneration [35]. Here, SHH is linked to glioblastoma.